20/20 BioLabs reports Q2 revenue growth, outlines Medicare strategy

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/28/2026

1. WDAY
2. ESTC
3. MRVL
4. AFRM
5. RBRK
6. S
7. GAP
8. DG
9. ULTA
10. NVDA

Go back to 20/20 BioLabs reports Q2 revenue growth, outlines Medicare strategy
(NASDAQ: AIDX) Delayed: 0.62 --0 (-0%)
Previous Close $0.62    52 Week High $ 
Open $0.62    52 Week Low $ 
Day High $0.67    P/E N/A 
Day Low $0.62    EPS $ 
Volume 120,754